DOCSLIB.ORG

Diagnosis and Treatment in Anhidrotic Ectodermal Dysplasia with Immunodeficiency Tomoki Kawai1, Ryuta Nishikomori1 and Toshio Heike1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnosis and Treatment in Anhidrotic Ectodermal Dysplasia with Immunodeficiency Tomoki Kawai1, Ryuta Nishikomori1 and Toshio Heike1 Allergology International. 2012;61:207-217 ! DOI: 10.2332 allergolint.12-RAI-0446 REVIEW ARTICLE Review Series: Primary Immunodeficiency and Related Diseases Diagnosis and Treatment in Anhidrotic Ectodermal Dysplasia with Immunodeficiency Tomoki Kawai1, Ryuta Nishikomori1 and Toshio Heike1 ABSTRACT Anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) is characterized according to its various manifestations, which include ectodermal dysplasia, vascular anomalies, osteopetrosis, and diverse immu- nological abnormalities such as susceptibility to pathogens, impaired antibody responses to polysaccharides, hypogammaglobulinemia, hyper-IgM syndrome, impaired natural killer cell cytotoxicity, and autoimmune dis- eases. Two genes responsible for EDA-ID have been identified: nuclear factor-κ B(NF-κ B) essential modula- tor (NEMO) for X-linked EDA-ID (XL-EDA-ID) and Iκ Bα for autosomal-dominant EDA-ID (AD-EDA-ID). Both genes are involved in NF-κB activation, such that mutations or related defects cause impaired NF-κB signaling. In particular, NEMO mutations are scattered across the entire NEMO gene in XL-EDA-ID patients, which ex- plains the broad spectrum of clinical manifestations and the difficulties associated with making a diagnosis. In this review, we focus on the pathophysiology of EDA-ID and different diagnostic strategies, which will be bene- ficial for early diagnosis and appropriate treatment. KEY WORDS anhidrotic ectodermal dysplasia with immunodeficiency, immunodeficiency, inflammation, NEMO, NF-kappaB inhibitor alpha treatment of EDA-ID, the physicians should be well INTRODUCTION aware of the broad spectrum of its clinical pheno- Anhidrotic ectodermal dysplasia with immunodefi- types. Moreover, in the genetic diagnosis of XL-EDA- ciency (EDA-ID) is a primary immunodeficiency dis- ID, the potential presence of a NEMO pseudogene order in which patients present with various manifes- and the occurrence of somatic mosaicism must be tations, such as EDA, vascular anomalies, and os- considered. In this review, we focus on the variable teopetrosis.1-5 The immunological features of EDA-ID clinical manifestations of XL-EDA-ID and the diagnos- include susceptibility to pathogens, impaired anti- tic precautions that can be taken in individuals at risk body response to polysaccharrides, hypogamma- for the disease. globulinemia, hyper IgM syndrome, impaired natural killer (NK) cell cytotoxicity, and autoimmune dis- ETIOLOGY OF EDA-ID eases.6 Two genes responsible for EDA-ID have been The first case of EDA-ID, in a boy who died of miliary identified: nuclear factor-κB(NF-κB) essential modu- tuberculosis, was reported by Frix et al. in 1986.8 The lator (NEMO) in X-linked EDA-ID (XL-EDA-ID) and second case involved a boy who suffered from multi- IκBα in autosomal-dominant EDA-ID (AD-EDA-ID). ple life-threatening infections caused by Pseudomonas Both genes are involved in NF-κB activation such aeruginosa, Mycobacterium avium, and cytomegalovi- that mutations or related defects cause impaired NF- rus infections.3 In spite of extensive searches for the κB signalling.5,7 For the appropriate diagnosis and cause of the refractory infections in these patients, 1Department of Pediatrics, Kyoto University Graduate School of Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606−8507, Japan. Medicine, Kyoto, Japan. Email: [email protected] Conflict of interest: No potential conflict of interest was disclosed. Received 21 March 2012. Correspondence: Ryuta Nishikomori, MD, PhD, Department of Pe- !2012 Japanese Society of Allergology diatrics, Kyoto University Graduate School of Medicine, 54 Allergology International Vol 61, No2, 2012 www.jsaweb.jp! 207 Kawai T et al. antigen LPS TNF-D CD40L TLR4 TNFR CD40 TCR TOLLIP MyD88 TRADD TRAF6 TRAF2 TRAF1 FADD TRAF3 IRAK TRAF2 CARMA1 BCL10 TRAF6 MALT1 RIP NEMO IKK-D IKK-E cytoplasm Phosphorylation P 㩷㩷㩷㸢polyubiquitination degradation INB INB in proteasome p50 p60 Ub p50 p60 nucleus NF-NB Fig. 1 NF-κB activation pathways associated with NEMO and IκBα. The major molecules involved in the TLR-4, TNFR, CD40, and TCR signalling pathways and NEMO-mediated NF-κB activation are depicted. TOLLIP, Toll-interacting protein; MyD, myeloid differentia- tion factor; IRAK, interleukin-1 receptor-associated kinase; TRAF, tumor necrosis factor re- ceptor-associated factor; TRADD, tumor necrosis factor receptor-associated death domain; FADD, fas-associated protein with death domain; RIP, receptor-interacting protein; CARMA, caspase recruitment domain-containing membrane-associated guanylate kinase protein; BCL, B-cell lymphoma protein; MALT, mucosa-associated lymphoid tissue lympho- ma translocation protein; Ub, poly-ubiquitin chain; P, phosphate. immunological dysfunctions were not identified. In mated incidence of XL-EDA-ID is 1 : 250,000 live male 1996, Abinun et al. described a young male patient births.6 In AD-EDA-ID, six patients and four IκBα with EDA-ID who had an impaired antibody response mutations have been reported thus far.7,12-15 to polysaccharide antigens.2 Their report was the first THE ROLES OF NEMO AND Iκ Bα IN THE to shed light on the mechanism of EDA-ID-associated κ immunodeficiency. In 2001, three groups were able NF- B ACTIVATION PATHWAY to show that defects in the NEMO gene are responsi- NF-κB transcription factors are critical regulators of ble for XL-EDA-ID. Those authors demonstrated that immunity, the stress response, apoptosis, and differ- the clinical manifestations of XL-EDA-ID, including entiation. Mammalian cells make use of two main NF- EDA and the immunological dysfunctions, were κB activation pathways, the canonical pathway and caused by impaired NF-κB activation due to the iden- the non-canonical pathway. The canonical pathway, in tified genetic alterations.5,9,10 In addition, in a 2003 pa- which NEMO and inhibitors of NF-κB(IκB) are es- per by Courtois et al., the etiology of AD-EDA-ID was sential control elements, is induced by most physi- determined to be a heterozygous gain-of-function mu- ological NF-κB stimuli.16 NEMO and IκBarealsoin- tation in the IκBα gene.7 As both forms of EDA-ID volved in the non-canonical NF-κB activation path- are typically diagnosed by genetic testing, NEMO way, albeit indirectly.17 Homo- or heterodimers of and IκBα mutations have been linked to a broad NF-κB proteins (p50, p52, RelB, and c-rel) are nor- spectrum of clinical phenotypes.11 Currently, the esti- mally retained in the cytoplasm through interactions 208 Allergology International Vol 61, No2, 2012 www.jsaweb.jp! Manifestations and Mutations in EDA-ID A NEMO gene exon 1d 1a 1b 1c 2 3 4 5 6 7 8 9 10 NEMO pseudogene B D311E D311N E315A L80P L153R R173G R217G R254G E319Q E391X D406VC417R,F,Y D113N A169P R175P R182P L227P A288G E331del3 Q403X Q348X 419 NH21 CC1 CC2 NUB LZ ZF COOH Id Ia Ib Ic II III IV V VI VII VIII IX X 5’ 1 1257 3’ +1 of the donor splice site of 769(-1)G 1056(-1)G>A exon1B G>T >C (del 353-373) 110_111insC(49X) Ex4_6del Ex4_6dup 811_28del 1166_78dup(398X) (233X) (del 271-276) 1161_67insC(394X) 1218insC(419X) 1235insC(419X) X420Wro(447X) C Serine 32 Serine 36 72 277 317 Phosphorylation NH2 Ankyrin Repeat Domains PSET COOH sites Q9X W11X E14X S32I Fig. 2 Schematic representations of the normal NEMO and IκBα genes. (A) The normal NEMO gene and a NEMO pseudo- gene. Schematic representation of the coding-region domain and reported mutations in NEMO (B) and IκBα (C). with IκB family proteins, which consist of IκBα,IκBβ, The human NEMO gene, located at Xq28, is a 23-kb and IκBε. In response to the appropriate signals, gene structured in nine exons and four alternative these three proteins are phosphorylated, polyubiquiti- non-coding first exons. A non-functional copy of the nated, and degraded though the ubiquitin-protea- NEMO gene, IKBKGP (also referred to as the some pathway (Fig. 1), thereby freeing NF-κBto NEMO pseudogene), is located 31.6 kb distal to exon translocate to the nucleus where it activates its target 10 (Fig. 2A). IKBKGP maps within a 35.7-kb dupli- genes.16 cated fragment that is oriented tail to tail with the The phosphorylation event in this sequence is car- NEMO gene and contains exons 3-10, with 99.8% ho- ried out by a high molecular mass, multiprotein mology.18 The ~48-kDa NEMO protein is composed kinase complex containing two subunits with kinase of two coiled coil (CC1, CC2) domains, a leucine- activity (IKK1!α and IKK2!β) and NEMO (IKK3!γ). zipper (LZ) domain, a NEMO ubiquitin-binding Allergology International Vol 61, No2, 2012 www.jsaweb.jp! 209 Kawai T et al. Table 1 Clinical and immune function associated with hypomorphic NEMO mutations in reported cases and Japanese cases Functional or clinical category Modifi ed - Hanson et al.11 Japanese cases Ectodermal dysplasia 40/52 ( 77%) 9/10 ( 90%) Osteopetrosis 5/65 ( 8%) 0/10 ( 0%) Lymphedema 5/65 ( 8%) 1/10 ( 10%) Autoimmune/infl ammatory disease 14/66 ( 23%) 5/10 ( 50%) Dead 24/66 ( 36%) 2/10 ( 20%) Infectious susceptibility 60/61 ( 98%) 10/10 (100%) Bacterial infection 45/52 ( 86%) 10/10 (100%) Mycobacterial infection 23/52 ( 44%) 4/10 ( 40%) Pneumocystis pneumonia 4/52 ( 21%) 0/10 ( 0%) DNA-virus infection 11/52 ( 21%) 1/10 ( 10%) Meningitis 12/61 ( 21%) 1/10 ( 10%) Pneumonia 19/61 ( 31%) 3/10 ( 30%) Sepsis/bacteremia 20/61 ( 33%) 5/10 ( 50%) Abscess 18/61 ( 30%) 3/10 ( 30%) Hypogammaglobulinemia 24/41 ( 59%) N.D. Specifi c antibody defi ciency 18/28 ( 64%) N.D. Impaired antibody response to polysaccharide 13/16 ( 94%) 3/3 (100%) Impaired NK cell cytotoxicity 10/10 (100%) N.D. (NUB) domain, and a zinc finger (ZF) domain (Fig. while phosphorylation of Ser32 and Ser36 in its phos- 2B).19 NEMO has no apparent catalytic activity but is phorylation domains triggers IκBα ubiquitination, instead required in activation of the kinase complex leading to degradation of the protein within the pro- in response to extracellular (or intracellular) stimuli, teasome and, in turn, the nuclear translocation of NF- such as members of the TIR (TLR-ligands, IL-1β,and κB and subsequent activation of its target genes.
Load more

Recommended publications
  • IDF Patient & Family Handbook
    Immune Deficiency Foundation Patient & Family Handbook for Primary Immunodeficiency Diseases This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. FIFTH EDITION COPYRIGHT 1987, 1993, 2001, 2007, 2013 IMMUNE DEFICIENCY FOUNDATION Copyright 2013 by Immune Deficiency Foundation, USA. REPRINT 2015 Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. The Immune Deficiency Foundation Patient & Family Handbook may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from the Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 110 West Road, Suite 300, Towson, MD 21204, USA; or by telephone at 800-296-4433. Immune Deficiency Foundation Patient & Family Handbook for Primary Immunodeficency Diseases 5th Edition This publication has been made possible through a generous grant from Baxalta Incorporated Immune Deficiency Foundation 110 West Road, Suite 300 Towson, MD 21204 800-296-4433 www.primaryimmune.org [email protected] EDITORS R. Michael Blaese, MD, Executive Editor Francisco A. Bonilla, MD, PhD Immune Deficiency Foundation Boston Children’s Hospital Towson, MD Boston, MA E. Richard Stiehm, MD M. Elizabeth Younger, CPNP, PhD University of California Los Angeles Johns Hopkins Los Angeles, CA Baltimore, MD CONTRIBUTORS Mark Ballow, MD Joseph Bellanti, MD R. Michael Blaese, MD William Blouin, MSN, ARNP, CPNP State University of New York Georgetown University Hospital Immune Deficiency Foundation Miami Children’s Hospital Buffalo, NY Washington, DC Towson, MD Miami, FL Francisco A.
    [Show full text]
  • WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure
    Journal of Clinical Immunology (2019) 39:532–556 https://doi.org/10.1007/s10875-019-00665-w CME REVIEW WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure Lauren E. Heusinkveld1,2 & Shamik Majumdar1 & Ji-Liang Gao1 & David H. McDermott1 & Philip M. Murphy1 Received: 22 April 2019 /Accepted: 26 June 2019 /Published online: 16 July 2019 # This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019 Abstract WHIM syndrome is a rare combined primary immunodeficiency disease named by acronym for the diagnostic tetrad of warts, hypogammaglobulinemia, infections, and myelokathexis. Myelokathexis is a unique form of non-cyclic severe congenital neutropenia caused by accumulation of mature and degenerating neutrophils in the bone marrow; monocytopenia and lympho- penia, especially B lymphopenia, also commonly occur. WHIM syndrome is usually caused by autosomal dominant mutations in the G protein-coupled chemokine receptor CXCR4 that impair desensitization, resulting in enhanced and prolonged G protein- and β-arrestin-dependent responses. Accordingly, CXCR4 antagonists have shown promise as mechanism-based treatments in phase 1 clinical trials. This review is based on analysis of all 105 published cases of WHIM syndrome and covers current concepts, recent advances, unresolved enigmas and controversies, and promising future research directions. Keywords Chemokine . CXCL12 . CXCR4 . CXCR2 . myelokathexis . human papillomavirus . plerixafor Historical Background [M:E] ratio with a “shift to the right”); and (3) numerous dysmorphic bone marrow neutrophils having cytoplasmic Myelokathexis was first described as a new type of severe hypervacuolation and hyperlobulated pyknotic nuclear lobes congenital neutropenia in 1964 by Krill and colleagues from connected by long thin strands (Fig.
    [Show full text]
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol
    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
    [Show full text]
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency
    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
    [Show full text]
  • A Curated Gene List for Reporting Results of Newborn Genomic Sequencing
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE A curated gene list for reporting results of newborn genomic sequencing Ozge Ceyhan-Birsoy, PhD1,2,3, Kalotina Machini, PhD1,2,3, Matthew S. Lebo, PhD1,2,3, Tim W. Yu, MD3,4,5, Pankaj B. Agrawal, MD, MMSC3,4,6, Richard B. Parad, MD, MPH3,7, Ingrid A. Holm, MD, MPH3,4, Amy McGuire, PhD8, Robert C. Green, MD, MPH3,9,10, Alan H. Beggs, PhD3,4, Heidi L. Rehm, PhD1,2,3,10; for the BabySeq Project Purpose: Genomic sequencing (GS) for newborns may enable detec- of newborn GS (nGS), and used our curated list for the first 15 new- tion of conditions for which early knowledge can improve health out- borns sequenced in this project. comes. One of the major challenges hindering its broader application Results: Here, we present our curated list for 1,514 gene–disease is the time it takes to assess the clinical relevance of detected variants associations. Overall, 954 genes met our criteria for return in nGS. and the genes they impact so that disease risk is reported appropri- This reference list eliminated manual assessment for 41% of rare vari- ately. ants identified in 15 newborns. Methods: To facilitate rapid interpretation of GS results in new- Conclusion: Our list provides a resource that can assist in guiding borns, we curated a catalog of genes with putative pediatric relevance the interpretive scope of clinical GS for newborns and potentially for their validity based on the ClinGen clinical validity classification other populations. framework criteria, age of onset, penetrance, and mode of inheri- tance through systematic evaluation of published evidence.
    [Show full text]
  • Case Report Osteopetrosis Complicated by Schizophrenia Results from Mutations on Chromosome 16
    Int J Clin Exp Med 2016;9(9):18673-18677 www.ijcem.com /ISSN:1940-5901/IJCEM0016860 Case Report Osteopetrosis complicated by schizophrenia results from mutations on Chromosome 16 Yuwei Zhang, Decai Chen, Fang Zhang, Qingguo Lv, Lizhi Tang, Nanwei Tong Division of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China Received September 25, 2015; Accepted December 8, 2015; Epub September 15, 2016; Published September 30, 2016 Abstract: Objective: To investigate the genetic pathogenesis and diagnosis of osteopetrosis, and its relationship with schizophrenia. Methods: Conducting extensive review of literature related to osteopetrosis patients with schizophre- nia, summing common disease genes and diagnosis of osteopetrosis in association with schizophrenia. Results and Conclusion: Osteopetrosis is a rare inherited metabolic bone disease, with 12 kinds of common disease genes. In particular, mutations at 16p13.3 are closely related to schizophrenia. In recent years, molecular studies have identified three genes on chromosome 16 closely associated with schizophrenia, located at 16p13.3, 16p11.2, 16p13.11. Thus osteopetrosis and schizophrenia may not be two independent diseases, and understanding their relationship may help to identify schizophrenia at an earlier stage in osteopetrosis patients with mutations of chro- mosome 16. Conversely, patients with a family history of schizophrenia may be at increased risk for developing osteopetrosis. Keywords: Osteopetrosis, schizophrenia, pathogenic gene, diagnosis Introduction the possibility of such an association in the present case study of a patient diagnosed with Osteopetrosis is an extremely rare hereditary both disorders and possessing common identi- metabolic bone disease characterized by a fied genetic mutations. In this study, the patient decrease in number or functionality of osteo- was given a written informed consent.
    [Show full text]
  • Patient & Family Handbook
    Immune Deficiency Foundation Patient & Family Handbook For Primary Immunodeficiency Diseases This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. SIXTH EDITION COPYRIGHT 1987, 1993, 2001, 2007, 2013, 2019 IMMUNE DEFICIENCY FOUNDATION Copyright 2019 by Immune Deficiency Foundation, USA. Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. The Immune Deficiency Foundation Patient & Family Handbook may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from the Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 110 West Road, Suite 300, Towson, MD 21204, USA; or by telephone at 800-296-4433. Immune Deficiency Foundation Patient & Family Handbook For Primary Immunodeficiency Diseases 6th Edition The development of this publication was supported by Shire, now Takeda. 110 West Road, Suite 300 Towson, MD 21204 800.296.4433 www.primaryimmune.org [email protected] Editors Mark Ballow, MD Jennifer Heimall, MD Elena Perez, MD, PhD M. Elizabeth Younger, Executive Editor Children’s Hospital of Philadelphia Allergy Associates of the CRNP, PhD University of South Florida Palm Beaches Johns Hopkins University Jennifer Leiding,
    [Show full text]
  • Curriculum Vitae
    Arthur S. Aylsworth, M.D. CURRICULUM VITAE Personal Information Name Arthur Selden Aylsworth Home Address 714A Greenwood Road, Chapel Hill, NC 27514 Home Phone (919) 942-7817 Office Address CB# 7487 - UNC Campus The University of North Carolina at Chapel Hill (UNC-CH) Chapel Hill, NC 27599-7487 Office Phone - 919 966-4202; Fax - 919-966-3025 Email [email protected] Education 1982-1983 Visiting Associate Research Professor, Department of Medicine, Duke University, Durham, NC 1970-1971 Research Fellow, Florida Heart Association 1969-1971 Post-Doctoral Fellow, Department of Pediatrics and the Institutional Division of Genetics, Endocrinology, and Metabolism, University of Florida College of Medicine, Gainesville, FL 1967-1969 Intern and Resident in Pediatrics, University of Florida College of Medicine, Shands Teaching Hospital, Gainesville, FL 1967 M.D., University of Pennsylvania School of Medicine, Philadelphia, PA 1963 B. Engineering Physics, Cornell University College of Engineering, Ithaca, NY Professional Experience - Employment History 2001 - Research Professor, Dept. of Genetics, UNC-CH 2001 - Member, UNC-CH Center for Genome Science 1995 - 2004 Chief, Division of Genetics and Metabolism, Dept. of Pediatrics, UNC-CH 1991-95 Acting Div. Chief, Pediatric Genetics and Metabolism, UNC-CH 1993 - Professor, Dept. of Pediatrics, Div. of Genetics and Metabolism, UNC-CH 1980 - 1993 Associate Prof., Dept. of Pediatrics, Div. Genetics and Metabolism, UNC-CH. 1975 - 1980 Assistant Prof., Dept. of Pediatrics, Div. Genetics and Metabolism, UNC-CH. 1980 - 2001 Research Scientist, the Neuroscience Center at UNC-CH (formerly Brain and Development Research Center, formerly Biological Sciences Research Center) 1977 - 1995 Director, Genetic Counseling Program, UNC-CH (Acting Director, 1976 - 1977) 1974 - Member, UNC Craniofacial Center (formerly the Oral-Facial and Communicative Disorders Program), UNC-CH 1974 - Medical Staff, University of North Carolina Hospitals, Chapel Hill 1973 - 1975 Instructor, Dept.
    [Show full text]
  • Ectodermal Dysplasia with Classical Clinical Presentation: a Rare Case Report
    IP Journal of Diagnostic Pathology and Oncology 2020;5(4):441–445 Content available at: https://www.ipinnovative.com/open-access-journals IP Journal of Diagnostic Pathology and Oncology Journal homepage: https://www.ipinnovative.com/journals/JDPO Case Report Ectodermal dysplasia with classical clinical presentation: A rare case report Nitesh Mohan1,*, P. K. Rathore2 1Dept. of Pathology, Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India 2Dept. of Dermatology, Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India ARTICLEINFO ABSTRACT Article history: Background: Ectodermal dysplasia is a syndrome consisting of heterogeneous group of hereditary Received 01-12-2020 malformations which have similar findings and are inherited genetically. These disorders affect the Accepted 10-12-2020 ectodermal derived tissues (hair, nails, teeth, skin and sweat glands) and lead to development of two or Available online 18-12-2020 more tissue anomalies with heterogeneous characteristics. Case History: We report a rare case of 16 year old male presenting to us with complaints of decreased sweating, itching all over skin when exposed to sun, hypodonti, madarosis and sparse scalp hair. Thorough Keywords: examination revealed classical syndromic anamolies. Skin biopsy revealed dyskeratosis and acantholysis Ectodermal dysplasia with reduced skin adenaxae. Hereditary disorders Conclusion: Ectodermal dysplasia is a heterogeneous group of hereditary malformations and irregularities Anamolies which have similar findings. Ectodermal dysplasia not only creates tissue malformations but, the quality of life of patients is also affected. © This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • Tetralogy of Fallot Is an Uncommon Manifestation of Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome
    Tetralogy of Fallot is an Uncommon Manifestation of Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Raffaele Badolato, MD, PhD1, Laura Dotta, MD1, Laura Tassone, PhD1, Giovanni Amendola, MD2, Fulvio Porta, MD3, Franco Locatelli, MD4, Lucia D. Notarangelo, MD3, Yves Bertrand5, Francoise Bachelerie, PhD6, and Jean Donadieu, MD, PhD7 Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare immunodeficiency dis- order. We report three patients with WHIM syndrome who are affected by Tetralogy of Fallot (TOF). This observation suggests a possible increased risk of TOF in WHIM syndrome and that birth presentation of TOF and neutropenia should lead to suspect WHIM syndrome. (J Pediatr 2012;161:763-5) arts, hypogammaglobulinemia, infections, and Results Wmyelokathexis (WHIM) syndrome is a rare im- munodeficiency disorder characterized by warts, We report the cases of 3 patients with WHIM syndrome who hypogammaglobulinemia, infections, and abnormal reten- are affected by TOF (Figure). Taking into consideration the tion of mature neutrophils in the bone marrow (myeloka- relatively poor prevalence of the two disorders, in the present thexis).1,2 This neutropenia, which is associated with report we show that patients with WHIM syndrome display a B and T lymphopenia and hypogammaglobulinemia, re- an increased risk to develop TOF. sults in an increased risk for bacterial infections. Patients The first patient is a 19-year-old man with a history of with WHIM syndrome present major and selective suscepti- WHIM syndrome identified at age 2.5 years, manifesting as bility to human papillomavirus that may manifest as cutane- severe neutropenia and recurrent pneumonias, resulting in ous warts and genital dysplasia and cancer.
    [Show full text]
  • Prevention of Infections During Primary Immunodeficiency
    Clinical Infectious Diseases Advance Access published September 28, 2014 INVITED ARTICLE IMMUNOCOMPROMISED HOSTS David R. Snydman, Section Editor Prevention of Infections During Primary Immunodeficiency Claire Aguilar,1,2,3 Marion Malphettes,1,4 Jean Donadieu,1,5 Olivia Chandesris,1,3,6 Hélène Coignard-Biehler,1,2,3 Emilie Catherinot,1,7 Isabelle Pellier,1,8 Jean-Louis Stephan,1,9 Vincent Le Moing,1,10 Vincent Barlogis,1,11 Felipe Suarez,1,3,6 Stéphane Gérart,3 Fanny Lanternier,1,2,3 Arnaud Jaccard,1,12 Paul-Henri Consigny,2 Florence Moulin,13 Odile Launay,14 Marc Lecuit,1,2,3 Olivier Hermine,1,3,6 Eric Oksenhendler,1,4 Capucine Picard,1,3,15,16,a Stéphane Blanche,1,3,16,a Alain Fischer,1,3,16,17,a Nizar Mahlaoui,1,3,16 and Olivier Lortholary1,2,3 1Centre de Référence des Déficits Immunitaires Héréditaires, and 2Centre d’Infectiologie Necker Pasteur, Hôpital Necker–Enfants Malades, Assistance publique–Hôpitaux de Paris (AP-HP), 3Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine, 4Département ’ 5 ’ 6 d Immunologie, Hôpital Saint-Louis, Service d Hémato-Oncologie Pédiatrique, Registre des Neutropénies Congénitales, Hôpital Trousseau, Service Downloaded from d’Hématologie Adulte, IHU Imagine, Hôpital Necker–Enfants Malades, AP-HP, Paris, 7Service de Pneumologie, Hôpital Foch, Suresnes, 8Unité d’Immuno- Hématologie-Oncologie Pédiatrique, Centre Hospitalier Universitaire (CHU) d’Angers, 9Unité d’Immuno-Hématologie-Oncologie Pédiatrique, CHU de Saint- Etienne, 10Service des Maladies Infectieuses et
    [Show full text]
  • Brain Abscess in a Patient with Osteopetrosis: a Rare Complication
    1 DOI: 10.4274/jcrpe.galenos.2020.2020.0039 Case report Brain Abscess in a Patient with Osteopetrosis: A Rare Complication Running title: Brain abscess in a patient with osteopetrosis Merve İŞERİ NEPESOV1, Eylem KIRAL2, Gürkan BOZAN2, Ömer KILIÇ1, Kürşat Bora ÇARMAN3, Coşkun YARAR3, Suzan ŞAYLISOY4, Ener Çağrı DİNLEYİCİ2 1Division of Pediatric Infectious Diseases, Eskişehir Osmangazi University Medical Faculty 2Division of Pediatric Intensive Care Unit, Eskişehir Osmangazi University Medical Faculty 3Division of Pediatric Neurology, Eskişehir Osmangazi University Medical Faculty 3Department of Radiology, Eskişehir Osmangazi University Medical Faculty What is already known on this topic? The most common infectious complication of osteopetrosis is osteomyelitis; in particular, mandibular osteomyelitis may be seen due to bone sclerosis and reduced vascular supply. Otolaryngological complications, such as recurrent otitis media, are also seen frequently. What this study adds? To our knowledge, this report is only the second published description of brain abscess in association with osteopetrosis. Therefore, routine otologic examination should be an integral component of management and plays an important role in preventing more severe complications, such as brain abscess. Abstract proof Brain abscess formation is extremely rare in patients with osteopetrosis. Herein, we report a case of viridans streptococci brain abscess in an immunocompromised child diagnosed with osteopetrosis. The patient presented with a sudden change in mental status
    [Show full text]